Business March 21, 2019
Biogen (BIIB) Shares Tank 29 Percent after Company Ends Alzheimer’s Drug Trials
The stock price of Biogen (NASDAQ: BIIB) suffered a steep decline after the biotechnology company announced its decision to stop…
Business March 21, 2019
The stock price of Biogen (NASDAQ: BIIB) suffered a steep decline after the biotechnology company announced its decision to stop…
By Cedric Dent